Dostawa leków cytostatycznych, w tym leków cytostatycznych niezbędnych do realizacji świadczeń z zakresu chemioterapii i programów lekowych dla potrzeb Beskidzkiego Centrum Onkologii – Szpitala Miejskiego im. Jana Pawła II w Bielsku – Białej
11 suppliers awarded•14 lots awarded•€35.99M awarded
Buyer: Beskidzkie Centrum Onkologii- Szpital Miejski im. Jana Pawła II w Bielsku-Białej. / Bielsko-Biała, Poland
Awarded value
€35.99M
Estimated value
€35.99M
Awarded at 100% of estimated value
Award date
May 07, 2026
Winners
11
Lots awarded
14
Award values
Notice total
€35.99M
Sum of lot awards
€23.37M
TED notice total and lot-level values do not exactly match.
Winners
Wrocław, POL
€8.9M This contract
499 award notices•1,666 awarded lots•€342.93M total
Budapeszt, HUN
€3.8M This contract
111 award notices•162 awarded lots•€78.15M total
Warszawa, POL
€3.8M This contract
106 award notices•169 awarded lots•€74.45M total
Poznań, POL
€1.7M This contract
4 award notices•4 awarded lots•€2.67M total
Warszawa, POL
€1.7M This contract
10 award notices•13 awarded lots•€5.00M total
€1.1M This contract
8 award notices•11 awarded lots•€3.10M total
Wrocław, POL
€841,274 This contract
19 award notices•22 awarded lots•€790,647 total
Warszawa, POL
€574,569 This contract
46 award notices•62 awarded lots•€14.71M total
Warszawa, POL
€544,179 This contract
62 award notices•73 awarded lots•€31.80M total
Warszawa, POL
€240,608 This contract
29 award notices•70 awarded lots•€2.77M total
€105,443 This contract
8 award notices•12 awarded lots•€1.48M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0010 | URTICA Sp. z o.o. | €8.4M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0004 | AstraZeneca Kft. | €3.8M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0005 | Roche Polska Sp. z o.o. | €3.8M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0008 | GSK Services Sp. z o. o. | €1.7M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0009 | Astellas Pharma Sp. z o.o. | €1.7M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0007 | JANSSEN-CILAG POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | €1.1M | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0012 | "ASCLEPIOS" SPÓŁKA AKCYJNA | €841,274 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0006 | AMGEN SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | €574,569 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0017 | ABBVIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ | €544,179 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0011 | URTICA Sp. z o.o. | €499,477 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0016 | Bialmed Sp. z o.o. | €170,950 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0003 | Baxter Polska Spółka z ograniczoną odpowiedzialnością | €105,443 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0013 | Not specified | €88,804 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) | |
| LOT-0015 | Bialmed Sp. z o.o. | €69,658 | Pharmaceutical products (33600000), Antineoplastic agents (33652100) |